Literature DB >> 2277112

High-performance liquid chromatography of iodo-doxorubicin and fluorescent metabolites in plasma samples.

K Mross1, U Mayer, K Hamm, D K Hossfeld.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2277112     DOI： 10.1016/s0378-4347(00)82321-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans.

Authors:  K Mross; U Mayer; K Hamm; K Burk; D K Hossfeld
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumors.

Authors:  K Mross; K Hamm; W Schultze-Seemann; K Burk; D K Hossfeld
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Effects of verapamil on the pharmacokinetics and metabolism of epirubicin.

Authors:  K Mross; K Hamm; D K Hossfeld
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

4.  Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.

Authors:  M Lehnert; K Mross; J Schueller; B Thuerlimann; N Kroeger; H Kupper
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.